These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3125723)

  • 21. [Incidence of primary and secondary resistance of M. tuberculosis in East Germany in 1983 in hospitalized patients].
    Kalich R; Käppler W
    Z Erkr Atmungsorgane; 1986; 167(3):254-60. PubMed ID: 3105189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
    Priĭmak AA; Dolzhanskiĭ VM; Sagalovich VIa; El'murzaeva AA
    Probl Tuberk; 1985; (8):49-52. PubMed ID: 3932999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study on the current incidence of bovine tuberculosis bacillus (Mycobacterium bovis) and on resistance to antitubercular antibiotics in human pulmonary tuberculosis].
    Viallier MJ
    J Med Lyon; 1968 Dec; 49(154):1857-86. PubMed ID: 4975074
    [No Abstract]   [Full Text] [Related]  

  • 28. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract]   [Full Text] [Related]  

  • 30. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriological bases of short-course chemotherapy.
    Grosset J
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):103-7. PubMed ID: 2999945
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary resistance to antituberculous drugs in a New Jersey hospital.
    Lin-Greenberg A; Deltieure M
    N J Med; 1987 Jun; 84(6):427-8. PubMed ID: 3112660
    [No Abstract]   [Full Text] [Related]  

  • 33. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN; Kerpel' RS
    Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
    [No Abstract]   [Full Text] [Related]  

  • 37. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in treating tuberculosis patients in the IB outpatient registry group].
    Smirnov GA; Valitova ZIu; Fattakhova RM; Anastas'ev VS
    Probl Tuberk; 1986; (4):12-5. PubMed ID: 3086863
    [No Abstract]   [Full Text] [Related]  

  • 39. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.